Supply chain professionals, logistics experts, pharmaceutical executives, regulatory affairs specialists, technology and solutions providers, healthcare providers, investors, and government representatives, are all invited to attend the 2nd BioPharma Supply Chain & Logistics Nexus to be held in Philadelphia, PA, October 17-18, 2023. This diverse mix of attendees will get a unique platform for collaboration, knowledge sharing, and networking, ensuring a remarkable event for all those involved in the BioPharma supply chain and logistics ecosystem.
The BioPharma industry has always been a beacon of advancement and unwavering innovation, providing life-saving therapies and medicines to innumerable individuals across the globe. However, it’s important to ensure that these essential medications reach their destination in a timely manner amidst the…
To learn more, please visit https://ibn.fm/RHORL.
About InvestorWire
InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer
InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]
InvestorWire is powered by IBN